|
Name |
3-[[(1R)-1,6-dimethyl-2-prop-1-enyl-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
|
| Molecular Formula | C22H31NO4 | |
| IUPAC Name* |
3-[[(1R)-1,6-dimethyl-2-prop-1-enyl-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
|
|
| SMILES |
CC=CC1C=CC2CC(CCC2[C@@]1(C)C(=C3C(=O)C(N(C3=O)C)CO)O)C
|
|
| InChI |
InChI=1S/C22H31NO4/c1-5-6-15-9-8-14-11-13(2)7-10-16(14)22(15,3)20(26)18-19(25)17(12-24)23(4)21(18)27/h5-6,8-9,13-17,24,26H,7,10-12H2,1-4H3/t13?,14?,15?,16?,17?,22-/m0/s1
|
|
| InChIKey |
QNQBPPQLRODXET-MEQYQKDTSA-N
|
|
| Synonyms |
Equisetin; 57749-43-6
|
|
| CAS | NA | |
| PubChem CID | 146159249 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 373.5 | ALogp: | 4.1 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 77.8 | Aromatic Rings: | 3 |
| Heavy Atoms: | 27 | QED Weighted: | 0.341 |
| Caco-2 Permeability: | -4.747 | MDCK Permeability: | 0.00001120 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.001 |
| Blood-Brain-Barrier Penetration (BBB): | 0.972 | Plasma Protein Binding (PPB): | 97.33% |
| Volume Distribution (VD): | 1.39 | Fu: | 2.88% |
| CYP1A2-inhibitor: | 0.297 | CYP1A2-substrate: | 0.852 |
| CYP2C19-inhibitor: | 0.137 | CYP2C19-substrate: | 0.629 |
| CYP2C9-inhibitor: | 0.527 | CYP2C9-substrate: | 0.753 |
| CYP2D6-inhibitor: | 0.232 | CYP2D6-substrate: | 0.618 |
| CYP3A4-inhibitor: | 0.542 | CYP3A4-substrate: | 0.256 |
| Clearance (CL): | 4.058 | Half-life (T1/2): | 0.659 |
| hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.006 |
| Drug-inuced Liver Injury (DILI): | 0.107 | AMES Toxicity: | 0.036 |
| Rat Oral Acute Toxicity: | 0.109 | Maximum Recommended Daily Dose: | 0.103 |
| Skin Sensitization: | 0.067 | Carcinogencity: | 0.035 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.02 |
| Respiratory Toxicity: | 0.797 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002818 | ![]() |
0.674 | D0I5DS | ![]() |
0.259 | ||
| ENC003491 | ![]() |
0.636 | D08PIQ | ![]() |
0.248 | ||
| ENC005181 | ![]() |
0.624 | D0CZ1Q | ![]() |
0.248 | ||
| ENC005182 | ![]() |
0.624 | D04SFH | ![]() |
0.248 | ||
| ENC003630 | ![]() |
0.600 | D0E9KA | ![]() |
0.240 | ||
| ENC003021 | ![]() |
0.495 | D0D2TN | ![]() |
0.237 | ||
| ENC003132 | ![]() |
0.449 | D0C8HR | ![]() |
0.236 | ||
| ENC005774 | ![]() |
0.418 | D0IT2G | ![]() |
0.233 | ||
| ENC004322 | ![]() |
0.418 | D00GOS | ![]() |
0.233 | ||
| ENC004321 | ![]() |
0.418 | D07DVK | ![]() |
0.233 | ||